https://nyulangone.org/news/perlmutter-cancer-center-clinical-trial-aims-use-circulating-tumor-dna-biomarker-adjuvant-therapy-people-colorectal-cancer
Perlmutter Cancer Center Clinical Trial Aims to Use Circulating Tumor DNA as Biomarker for Adjuvant...
Dr. Michael Shusterman, at NYU Langone’s Perlmutter Cancer Center, uses ctDNA to determine who can forgo additional colorectal cancer treatment. Learn more.
perlmutter cancer centercirculating tumor dnaclinical trialaimsuse
https://nyulangone.org/news/perlmutter-cancer-center-joins-call-get-cancer-preventing-hpv-vaccination-back-track
Perlmutter Cancer Center Joins Call to Get Cancer-Preventing HPV Vaccination Back on Track | NYU...
NYU Langone’s Perlmutter Cancer Center is joining other cancer centers to get the human papillomavirus (HPV) vaccination back on track. Learn more.
perlmutter cancer centerback on trackcall tohpv vaccinationjoins
https://nyulangone.org/news/perlmutter-cancer-center-medical-oncologist-advances-treatments-people-lymphoma
Perlmutter Cancer Center Medical Oncologist Advances Treatments for People with Lymphoma | NYU...
Dr. Catherine S. Diefenbach, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, advances treatments for people with lymphoma. Learn more.
perlmutter cancer centermedicaloncologistadvancestreatments